Indices: Stock Market Update: Nifty Pharma Index Down 0.12%

NEW DELHI: The Nifty Pharma index closed on a negative note on Thursday.

Shares of Laurus Labs Ltd. (up 2.82 percent), Mankind Pharma Ltd. (up 2.47 percent), Ipca Laboratories Ltd. (up 2.25 percent), Sanofi India Ltd. (up 2.21 percent) and Glenmark Pharmaceuticals Ltd. (up 1.36 percent) ended the day as the top gainers in the group.

On the other hand, Cipla Ltd. (down 1.47 per cent), Dr. Reddy’s Laboratories Ltd. (down 1.35 per cent), Zydus Lifesciences Ltd. (down 1.14 per cent), Aurobindo Pharma Ltd. (down 1.08 per cent) and Granules India Ltd. (down 0.8 per cent) ended as the top losers of the day.

The Nifty Pharma index closed down 0.12 per cent at 23,156.7.

The benchmark NSE Nifty50 index closed 53.61 points lower at 25,145.1, while the BSE Sensex was down 151.48 points at 82,201.16. Among the 50 stocks in the Nifty index, 18 ended in the green, while 32 closed in the red. Shares of Vodafone Idea, GMR Infra, Zomato, Ola Electric Mobilit and JM Financial were among the most traded stocks on the NSE. Shares of Nupur Recyclers, Premier Energies, Nectar Lifesc, Alpa Labs and Shriram EPC hit fresh 52-week highs today, while Stampede Cap(DVR), Globale Tessile, Mahalaxmi Fabric Mil, Revathi Equipment and Suumaya Lifestyle hit fresh 52-week lows.

Source link

Disclaimer:
The information contained in this post is for general information purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the post for any purpose.
We respect the intellectual property rights of content creators. If you are the owner of any material featured on our website and have concerns about its use, please contact us. We are committed to addressing any copyright issues promptly and will remove any material within 2 days of receiving a request from the rightful owner.

Leave a Comment